WallStSmart
ZJYL

JIN MEDICAL INTERNATIONAL LTD. Ordinary Shares

NASDAQ: ZJYL · HEALTHCARE · MEDICAL INSTRUMENTS & SUPPLIES

$1.94
-3.00% today

Updated 2026-10-02

Market cap
$144.85M
P/E ratio
9.70
P/S ratio
7.34x
EPS (TTM)
$0.20
Dividend yield
—
52W range
$2 – $12
Volume
0.9M

WallStSmart proprietary scores

19
out of 100
Grade: F
Strong Sell
Investment rating
2.7
Growth
F
5.5
Quality
C+
3.5
Profitability
D
6.7
Valuation
B
1/9
Piotroski F-Score
Weak
2.2
Altman Z-Score
Grey zone
—
Industry rank
—
View all highly rated stocks (75+) →267 stocks currently score above 75

Price targets

Analyst target
$0.07
-96.39%
12-Month target
$0.07
-96.39%
Intrinsic (DCF)
—
Margin of safety
—

Price chart

Stock snapshot

Strengths
Insufficient data
Risks
- Piotroski 1/9 — weak financial health
- Negative free cash flow $-2.72M
- Revenue declining -9.70% QoQ

Key financials

Revenue Net Income Free Cash Flow
Metric2022202320242025TTM
Revenue$19.19M$19.82M$23.50M$20.69M$19.73M
Net income$2.71M$2.88M$3.68M$1.19M$-107735.00
EPS————$0.20
Free cash flow$1.54M$2.99M$-2.33M$-3.73M$-2.72M
Profit margin14.10%14.52%15.64%5.76%5.95%

Peer comparison

CompanyMkt CapScoreGrowthProfitValueQualityMoSRating
ZJYL$144.85M192.73.56.75.5—Avoid
LLY$1.03T769.310.05.06.0—Strong Buy
JNJ$648.67B594.78.52.75.5-89.24%Buy
ABBV$454.36B736.78.54.05.0-73.03%Strong Buy
MRK$365.34B364.04.52.05.0-74.53%Hold
UNH$333.27B627.35.55.35.5-11.87%Buy

Smart narrative

JIN MEDICAL INTERNATIONAL LTD. Ordinary Shares trades at $1.94. representing a P/E of 9.70x trailing earnings. Our Smart Value Score of 19/100 indicates the stock is weak. The company scores 1/9 on the Piotroski F-Score. With an Altman Z-Score of 2.18, it sits in the grey zone. TTM revenue stands at $19.73M. with profit margins at 5.95%.

Frequently asked questions

What is JIN MEDICAL INTERNATIONAL LTD. Ordinary Shares's stock price?

JIN MEDICAL INTERNATIONAL LTD. Ordinary Shares (ZJYL) trades at $1.94, on a P/E of 9.7x and a P/S of 7.3x. Those multiples show what the market is paying for each dollar of earnings and sales, which is the real starting point for judging whether the price is reasonable.

Is JIN MEDICAL INTERNATIONAL LTD. Ordinary Shares overvalued?

JIN MEDICAL INTERNATIONAL LTD. Ordinary Shares carries a Smart Value Score of 19/100 (Grade F), which we rate Strong Sell. That score blends growth, quality, and valuation into one read.

What is the price target of JIN MEDICAL INTERNATIONAL LTD. Ordinary Shares (ZJYL)?

The 12-month analyst consensus target is $0.07, about 96.4% below the current $1.94. A consensus target is the average of Wall Street's 12-month forecasts, so it works as a sentiment gauge rather than a guarantee, and it resets with every earnings cycle.

What is JIN MEDICAL INTERNATIONAL LTD. Ordinary Shares's revenue?

JIN MEDICAL INTERNATIONAL LTD. Ordinary Shares's trailing twelve-month revenue is $19.73M. Revenue scale anchors the valuation multiples and shows whether growth is reaching the top line, so it is best read alongside margin and growth trends to see if that revenue is getting more profitable over time.

Altman Z-Score?

JIN MEDICAL INTERNATIONAL LTD. Ordinary Shares's Altman Z-Score is 2.18, which places it in the grey zone. The Altman Z-Score gauges bankruptcy risk from profitability, leverage, and asset efficiency, and a higher reading points to lower financial distress risk.

Company info

SectorHEALTHCARE
IndustryMEDICAL INSTRUMENTS & SUPPLIES
CountryUSA
ExchangeNASDAQ
CurrencyUSD

Quick metrics

P/S ratio7.34x
ROE3.72%
Beta7.33
50D MA$2.32
200D MA$2.59
Shares out0.07B
Float0.06B
Short ratio—
Avg volume0.9M

Performance

1 week—
1 month—
3 months—
YTD—
1 year—
3 years—
5 years—